Bilateral pheochromocytoma as first presentation of von Hippel-Lindau disease in a Chinese family

Chinese Medical Sciences Journal

Volumn 24, Issue 4, 2009, Pages 197-201

  Tong, An Ii ^a   Zeng, Zheng Pei ^a   Zhou, Ya Ru ^a   Yuan, Tao ^a   Cao, Cai Xia ^a   Zhang, Jing ^a   Li, Ming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Familial pheochromocytoma; Gene mutation; Von Hippel Lindau disease

Indexed keywords

GENOMIC DNA; VON HIPPEL LINDAU PROTEIN;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CRYOTHERAPY; DNA EXTRACTION; EARLY DIAGNOSIS; EXON; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HEMANGIOBLASTOMA; HUMAN; MALE; MISSENSE MUTATION; PANCREAS TUMOR; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; VON HIPPEL LINDAU DISEASE;

EID: 75749100307     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(10)60001-6     Document Type: Article

References (14)

1. Bornstein SR, Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma: increasing importance for clinical decision making. Ann N Y Acad Sci 2006; 1073:94-103.
2. Bryant J, Farmer J, Kessler LJ, et al. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 2003; 95:1196-204.
3. Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci 2006; 1073:1-20.
4. Tong AL, Zeng ZP, Li HZ, et al. von Hippel-Lindau gene mutation in non-syndromic familial pheochromocytoma. Ann N Y Acad Sci 2006; 1073:203-7.
5. Zhou DH, Wang YM, Lan T, et al. Mutation screening of VHL gene in a Chinese family with nonsyndromic pheochromocytoma. Chin J Med Genetics 2007; 24:365-8.
6. Pan JH, Liu WM, Huang YN. Familial and genetic researches of two Chinese kindred with von Hippel-Lindau disease. Chin J Urology 2006; 127:5-8.
7. Guo HF, Gong K, Zou SM, et al. Somatic mutations of VHL gene and HIF-Ia expression in primary renal clear cell carcinomas. Chin J Surg 2004; 42:196-200.
8. Shuin T, Yamasaki I, Tamura K, et al. von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 2006; 36:337-43.
9. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 2003; 361:2059-67.
10. Zbar B, Kishida T, Chen F, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996; 8: 348-57.
11. Hes FJ, Lips CJ, Vander Luijt RB. Molecular genetic aspects of von Hippel-Lindau (VHL) disease and criteria for DNA analysis in subjects at risk. Neth J Med 2001; 59:235-43.
12. Friedrich CA. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 2001; 10:763-7.
13. Iida K, Okimura Y, Takahashi K, et al. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred. Int J Mol Med 2004; 13:401-4.
14. Langrehr JM, Bahra M, Kristiansen G, et al. Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel-Lindau disease in childhood. J Pediatr Surg 2007; 42: 1291-4.